In Vitro Diagnostics

Sherlock Biosciences

How molecular diagnostics using CRISPR, synthetic biology, and artificial intelligence can solve challenges ranging from faster pathogen detection to simpler cancer screening

×

Please feel out the form below and someone from our team will contact you shortly.

Duration: 57:51 Recorded January 2024

Guests

  • Bryan Dechairo CEO, Sherlock Biosciences
  • Julie Garlikov CCO, Sherlock Biosciences

Transcript

On Point video shorts from the episode

First Authorized Use

Becoming the first FDA authorized use of CRISPR

Global Health

Investor focus on global health

AI Enabled

Open-source product development enabled by AI

Future Healthcare

Your future healthcare journey

Commercial Challenges

Challenges commercializing high-tech, low-cost products

Population Health

Bending the curve on population health

Better Diagnostics

Raising the stakes in the diagnostics industry

Life Sciences CEO

The role of life sciences CEO

Health Information

Providing access to health information with diagnostic tests

User Experience

Improving the user experience in diagnostic testing

Healthcare Access

Healthcare access for underserved communities
RP-ST-002_in-vitro-diagnostics_cover_2550x3300
Part of the Study

In Vitro Diagnostics

What it takes to get a diagnostic to patients, and understanding the technologies, materials, manufacturing methods, and regulatory pathways for in vitro diagnostics

Additional Reading

Content Card - Just Mighty - Boyd - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But the odds are against you. We help you turn Just Might into Just Mighty.